Cargando…
Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis
OBJECTIVE: To investigate the results of real-world application of non-myeloablative autologous HSCT for multiple sclerosis (MS). METHODS: Between July 2003 and October 2019 at a single center (Northwestern University), 414 patients with relapsing remitting MS (RRMS) and 93 patients with newly diagn...
Autores principales: | Burt, Richard K., Han, Xiaoqiang, Quigley, Kathleen, Helenowski, Irene B., Balabanov, Roumen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503710/ https://www.ncbi.nlm.nih.gov/pubmed/34633525 http://dx.doi.org/10.1007/s00415-021-10820-2 |
Ejemplares similares
-
The Cost Effectiveness of Immunoglobulin vs. Hematopoietic Stem Cell Transplantation for CIDP
por: Burt, Richard K., et al.
Publicado: (2021) -
Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
por: Pandit, Awadh Kishor, et al.
Publicado: (2015) -
Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018) -
Molecular Mechanisms of Oligodendrocyte Injury in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
por: Patel, Jilpa, et al.
Publicado: (2012) -
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
por: Casanova, Bonaventura, et al.
Publicado: (2017)